echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Targeting antibodies can "break the prevention" of breast tumors

    Targeting antibodies can "break the prevention" of breast tumors

    • Last Update: 2021-12-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Science and Technology Daily, Beijing, November 4 (Reporter Zhang Mengran) American researchers have discovered a key molecule in certain types of breast cancer that can prevent immune cells from entering the tumor to kill the cancer cells inside


    The lead author of the paper, Dr.


    Li Rong's team studied triple-negative breast cancer, which is an aggressive cancer that accounts for about 15% of all breast cancer cases


    Researchers evaluated the impact of removing DDR1 in multiple preclinical models


    Combining these new findings, researchers have developed a therapeutic DDR1 targeting antibody that can break that line of defense and help immune cells cross the barrier to kill tumors


    Researchers say that the discovery of the important role of DDR1 in anti-cancer is a major advancement that may change the way of treatment


    Editor-in-chief

    Editor-in-chief

    Breast cancer is the type of cancer that causes the most female deaths in the world, and triple-negative breast cancer is one of the most difficult subtypes, because compared to other breast cancers, it has a younger age of onset and is easier to metastasize-especially What is tricky in the medical profession is that the probability of recurrence after surgery is also higher


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.